FirstBehavior® | Behavioral Psychology

A diagnosis became a campaign issue. Here is what the record shows. In September 2025, the President stood in the Roosevelt Room and told American families that a cause of autism spectrum disorder had been identified and a treatment was at hand. The FDA would update labels on acetaminophen and fast-track approval of leucovorin as a treatment for autism-related speech deficits. The FDA Commissioner called it “opening the door to the first FDA-recognized treatment for autism.”